LONZA N | 607.40 / +1.37% |
Date/Time | 01/25 / 17:30 |
Chg. / Chg.(%) | 8.20 / +1.37% |
Bid | - / 40 |
Ask | - / 304 |
Open | 601.80 |
Previous Close | 599.20 |
High | 610.80 |
Low | 597.20 |
Volume [CHF] | 149,396,823.20 |
Volume [Units] | 246,639 |
Price fixings | 7450 |
ISIN | CH0013841017 |
Security | LONN |
Exchange | SIX Swiss Exchange |
Type | Stock |
Bid Size | Bid | Ask | Ask size |
---|---|---|---|
40 | - | - | 304 |
500 | 604.00 | 607.00 | 7 |
100 | 602.00 | 610.00 | 200 |
100 | 601.20 | 610.80 | 20 |
100 | 600.20 | 612.00 | 704 |
71 | 600.00 | 613.00 | 137 |
30 | 599.60 | 614.00 | 7 |
200 | 598.00 | 614.40 | 25 |
20 | 597.20 | 615.00 | 1,550 |
100 | 596.00 | 616.00 | 100 |
News
- Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
12/23/2020 / 14:00 - GlobeNewswire - Recro Announces Executive Changes
12/16/2020 / 13:00 - GlobeNewswire - Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
12/07/2020 / 22:05 - GlobeNewswire